Avalo Therapeutics, Inc.

NASDAQ (USD): Avalo Therapeutics, Inc. (AVTX)

Last Price

4.42

Today's Change

+0.01 (0.22%)

Day's Change

4.30 - 4.55

Trading Volume

12,520

Financial
Reported Currency in USD
Market Cap

Market Cap

3 Million

Shares Outstanding

0 Million

Latest Quarter

Latest Quarter

30-Sep-2023 [Q3]

Announcement Date

09-Nov-2023

Reported Currency

USD

Revenue QoQ | YoY

-63.30% | -98.42%

NP QoQ | YoY

36.19% | -263.78%

Latest Annual

Latest Annual

31-Dec-2022

Announcement Date

29-Mar-2023

Reported Currency

USD

Revenue | Net Profit

18,051,000.00 | -41,658,000.00

EPS | EPS Diluted

-4.43 Cent | -4.43 Cent

YoY

50.61%

NP Margin

-230.78%

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment